IL-17A, p53, and plasminogen activator inhibitor (PAI)-1 were higher in smokers with COPD than in healthy smokers (HSs) and healthy control subjects (HCs) (Gouda et al., 2018a). This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.